nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone Propionate—PGR—multiple sclerosis	0.0937	1	CbGaD
Fluticasone Propionate—Corticosteroid Hormone Receptor Agonists—Methylprednisolone—multiple sclerosis	0.0582	0.178	CiPCiCtD
Fluticasone Propionate—Methylprednisolone—multiple sclerosis	0.0576	0.254	CrCtD
Fluticasone Propionate—Betamethasone—multiple sclerosis	0.0566	0.25	CrCtD
Fluticasone Propionate—Dexamethasone—multiple sclerosis	0.0566	0.25	CrCtD
Fluticasone Propionate—Corticosteroid Hormone Receptor Agonists—Dexamethasone—multiple sclerosis	0.056	0.172	CiPCiCtD
Fluticasone Propionate—Corticosteroid Hormone Receptor Agonists—Betamethasone—multiple sclerosis	0.056	0.172	CiPCiCtD
Fluticasone Propionate—Triamcinolone—multiple sclerosis	0.0553	0.245	CrCtD
Fluticasone Propionate—Corticosteroid Hormone Receptor Agonists—Triamcinolone—multiple sclerosis	0.0541	0.166	CiPCiCtD
Fluticasone Propionate—Corticosteroid Hormone Receptor Agonists—Prednisolone—multiple sclerosis	0.0524	0.161	CiPCiCtD
Fluticasone Propionate—Corticosteroid Hormone Receptor Agonists—Prednisone—multiple sclerosis	0.0495	0.152	CiPCiCtD
Fluticasone Propionate—NR3C2—Betamethasone—multiple sclerosis	0.0184	0.127	CbGbCtD
Fluticasone Propionate—NR3C2—Prednisolone—multiple sclerosis	0.0182	0.126	CbGbCtD
Fluticasone Propionate—SERPINA6—Triamcinolone—multiple sclerosis	0.0152	0.105	CbGbCtD
Fluticasone Propionate—SERPINA6—Prednisolone—multiple sclerosis	0.0128	0.0887	CbGbCtD
Fluticasone Propionate—PGR—Betamethasone—multiple sclerosis	0.0119	0.0822	CbGbCtD
Fluticasone Propionate—NR3C2—Dexamethasone—multiple sclerosis	0.0107	0.074	CbGbCtD
Fluticasone Propionate—NR3C1—Methylprednisolone—multiple sclerosis	0.00934	0.0646	CbGbCtD
Fluticasone Propionate—NR3C1—Triamcinolone—multiple sclerosis	0.00708	0.0489	CbGbCtD
Fluticasone Propionate—PGR—Dexamethasone—multiple sclerosis	0.00692	0.0478	CbGbCtD
Fluticasone Propionate—NR3C1—Betamethasone—multiple sclerosis	0.00607	0.042	CbGbCtD
Fluticasone Propionate—NR3C1—Prednisolone—multiple sclerosis	0.00599	0.0414	CbGbCtD
Fluticasone Propionate—NR3C1—Prednisone—multiple sclerosis	0.00566	0.0391	CbGbCtD
Fluticasone Propionate—NR3C1—Dexamethasone—multiple sclerosis	0.00353	0.0244	CbGbCtD
Fluticasone Propionate—CYP3A4—Fingolimod—multiple sclerosis	0.00202	0.014	CbGbCtD
Fluticasone Propionate—Fluticasone furoate—Dexamethasone—multiple sclerosis	0.00179	0.0105	CrCrCtD
Fluticasone Propionate—Fluticasone furoate—Betamethasone—multiple sclerosis	0.00179	0.0105	CrCrCtD
Fluticasone Propionate—Fluticasone furoate—Triamcinolone—multiple sclerosis	0.00175	0.0103	CrCrCtD
Fluticasone Propionate—CYP3A7—Dexamethasone—multiple sclerosis	0.00169	0.0117	CbGbCtD
Fluticasone Propionate—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.00169	0.0117	CbGbCtD
Fluticasone Propionate—Flumethasone Pivalate—Methylprednisolone—multiple sclerosis	0.00163	0.00963	CrCrCtD
Fluticasone Propionate—Flumethasone Pivalate—Dexamethasone—multiple sclerosis	0.00161	0.00948	CrCrCtD
Fluticasone Propionate—Flumethasone Pivalate—Betamethasone—multiple sclerosis	0.00161	0.00948	CrCrCtD
Fluticasone Propionate—Difluprednate—Methylprednisolone—multiple sclerosis	0.00158	0.00932	CrCrCtD
Fluticasone Propionate—Halobetasol Propionate—Methylprednisolone—multiple sclerosis	0.00158	0.00932	CrCrCtD
Fluticasone Propionate—Flumethasone Pivalate—Triamcinolone—multiple sclerosis	0.00157	0.00926	CrCrCtD
Fluticasone Propionate—Halobetasol Propionate—Betamethasone—multiple sclerosis	0.00156	0.00918	CrCrCtD
Fluticasone Propionate—Difluprednate—Betamethasone—multiple sclerosis	0.00156	0.00918	CrCrCtD
Fluticasone Propionate—Halobetasol Propionate—Dexamethasone—multiple sclerosis	0.00156	0.00918	CrCrCtD
Fluticasone Propionate—Difluprednate—Dexamethasone—multiple sclerosis	0.00156	0.00918	CrCrCtD
Fluticasone Propionate—Halobetasol Propionate—Triamcinolone—multiple sclerosis	0.00152	0.00897	CrCrCtD
Fluticasone Propionate—Difluprednate—Triamcinolone—multiple sclerosis	0.00152	0.00897	CrCrCtD
Fluticasone Propionate—Prednicarbate—Methylprednisolone—multiple sclerosis	0.00149	0.00877	CrCrCtD
Fluticasone Propionate—Fluocinonide—Methylprednisolone—multiple sclerosis	0.00149	0.00877	CrCrCtD
Fluticasone Propionate—Clocortolone—Methylprednisolone—multiple sclerosis	0.00149	0.00877	CrCrCtD
Fluticasone Propionate—Fluocinonide—Dexamethasone—multiple sclerosis	0.00146	0.00863	CrCrCtD
Fluticasone Propionate—Fluocinonide—Betamethasone—multiple sclerosis	0.00146	0.00863	CrCrCtD
Fluticasone Propionate—Prednicarbate—Dexamethasone—multiple sclerosis	0.00146	0.00863	CrCrCtD
Fluticasone Propionate—Clocortolone—Betamethasone—multiple sclerosis	0.00146	0.00863	CrCrCtD
Fluticasone Propionate—Clocortolone—Dexamethasone—multiple sclerosis	0.00146	0.00863	CrCrCtD
Fluticasone Propionate—Beclomethasone—Dexamethasone—multiple sclerosis	0.00146	0.00863	CrCrCtD
Fluticasone Propionate—Beclomethasone—Betamethasone—multiple sclerosis	0.00146	0.00863	CrCrCtD
Fluticasone Propionate—Prednicarbate—Betamethasone—multiple sclerosis	0.00146	0.00863	CrCrCtD
Fluticasone Propionate—Fluocortolone—Methylprednisolone—multiple sclerosis	0.00144	0.00852	CrCrCtD
Fluticasone Propionate—Prednicarbate—Triamcinolone—multiple sclerosis	0.00143	0.00843	CrCrCtD
Fluticasone Propionate—Beclomethasone—Triamcinolone—multiple sclerosis	0.00143	0.00843	CrCrCtD
Fluticasone Propionate—Clocortolone—Triamcinolone—multiple sclerosis	0.00143	0.00843	CrCrCtD
Fluticasone Propionate—Fluocinonide—Triamcinolone—multiple sclerosis	0.00143	0.00843	CrCrCtD
Fluticasone Propionate—Fluocortolone—Dexamethasone—multiple sclerosis	0.00142	0.00838	CrCrCtD
Fluticasone Propionate—Fluocortolone—Betamethasone—multiple sclerosis	0.00142	0.00838	CrCrCtD
Fluticasone Propionate—Fluocinolone Acetonide—Methylprednisolone—multiple sclerosis	0.0014	0.00828	CrCrCtD
Fluticasone Propionate—Alclometasone—Methylprednisolone—multiple sclerosis	0.0014	0.00828	CrCrCtD
Fluticasone Propionate—Fluocortolone—Triamcinolone—multiple sclerosis	0.00139	0.00819	CrCrCtD
Fluticasone Propionate—Alclometasone—Dexamethasone—multiple sclerosis	0.00138	0.00815	CrCrCtD
Fluticasone Propionate—Fluocinolone Acetonide—Betamethasone—multiple sclerosis	0.00138	0.00815	CrCrCtD
Fluticasone Propionate—Fluocinolone Acetonide—Dexamethasone—multiple sclerosis	0.00138	0.00815	CrCrCtD
Fluticasone Propionate—Alclometasone—Betamethasone—multiple sclerosis	0.00138	0.00815	CrCrCtD
Fluticasone Propionate—Prednicarbate—Prednisone—multiple sclerosis	0.00136	0.008	CrCrCtD
Fluticasone Propionate—Alclometasone—Triamcinolone—multiple sclerosis	0.00135	0.00796	CrCrCtD
Fluticasone Propionate—Fluocinolone Acetonide—Triamcinolone—multiple sclerosis	0.00135	0.00796	CrCrCtD
Fluticasone Propionate—Amcinonide—Dexamethasone—multiple sclerosis	0.00134	0.00793	CrCrCtD
Fluticasone Propionate—Amcinonide—Betamethasone—multiple sclerosis	0.00134	0.00793	CrCrCtD
Fluticasone Propionate—Diflorasone—Methylprednisolone—multiple sclerosis	0.00133	0.00785	CrCrCtD
Fluticasone Propionate—Flunisolide—Methylprednisolone—multiple sclerosis	0.00133	0.00785	CrCrCtD
Fluticasone Propionate—Clobetasol propionate—Methylprednisolone—multiple sclerosis	0.00133	0.00785	CrCrCtD
Fluticasone Propionate—Prednicarbate—Prednisolone—multiple sclerosis	0.00132	0.00781	CrCrCtD
Fluticasone Propionate—Clocortolone—Prednisolone—multiple sclerosis	0.00132	0.00781	CrCrCtD
Fluticasone Propionate—Beclomethasone—Prednisolone—multiple sclerosis	0.00132	0.00781	CrCrCtD
Fluticasone Propionate—Fluocortolone—Prednisone—multiple sclerosis	0.00132	0.00777	CrCrCtD
Fluticasone Propionate—Amcinonide—Triamcinolone—multiple sclerosis	0.00131	0.00775	CrCrCtD
Fluticasone Propionate—Clobetasol propionate—Dexamethasone—multiple sclerosis	0.00131	0.00773	CrCrCtD
Fluticasone Propionate—Clobetasol propionate—Betamethasone—multiple sclerosis	0.00131	0.00773	CrCrCtD
Fluticasone Propionate—Flunisolide—Betamethasone—multiple sclerosis	0.00131	0.00773	CrCrCtD
Fluticasone Propionate—Diflorasone—Dexamethasone—multiple sclerosis	0.00131	0.00773	CrCrCtD
Fluticasone Propionate—Diflorasone—Betamethasone—multiple sclerosis	0.00131	0.00773	CrCrCtD
Fluticasone Propionate—Flunisolide—Dexamethasone—multiple sclerosis	0.00131	0.00773	CrCrCtD
Fluticasone Propionate—CYP3A4—Methylprednisolone—multiple sclerosis	0.0013	0.00901	CbGbCtD
Fluticasone Propionate—Paramethasone—Methylprednisolone—multiple sclerosis	0.0013	0.00765	CrCrCtD
Fluticasone Propionate—Fluocortolone—Prednisolone—multiple sclerosis	0.00129	0.00759	CrCrCtD
Fluticasone Propionate—Alclometasone—Prednisone—multiple sclerosis	0.00128	0.00756	CrCrCtD
Fluticasone Propionate—Diflorasone—Triamcinolone—multiple sclerosis	0.00128	0.00755	CrCrCtD
Fluticasone Propionate—Flunisolide—Triamcinolone—multiple sclerosis	0.00128	0.00755	CrCrCtD
Fluticasone Propionate—Clobetasol propionate—Triamcinolone—multiple sclerosis	0.00128	0.00755	CrCrCtD
Fluticasone Propionate—Paramethasone—Dexamethasone—multiple sclerosis	0.00128	0.00753	CrCrCtD
Fluticasone Propionate—Paramethasone—Betamethasone—multiple sclerosis	0.00128	0.00753	CrCrCtD
Fluticasone Propionate—Desoximetasone—Methylprednisolone—multiple sclerosis	0.00127	0.00747	CrCrCtD
Fluticasone Propionate—CYP3A5—Dexamethasone—multiple sclerosis	0.00126	0.00874	CbGbCtD
Fluticasone Propionate—Alclometasone—Prednisolone—multiple sclerosis	0.00125	0.00738	CrCrCtD
Fluticasone Propionate—Fluocinolone Acetonide—Prednisolone—multiple sclerosis	0.00125	0.00738	CrCrCtD
Fluticasone Propionate—Paramethasone—Triamcinolone—multiple sclerosis	0.00125	0.00736	CrCrCtD
Fluticasone Propionate—Amcinonide—Prednisone—multiple sclerosis	0.00125	0.00735	CrCrCtD
Fluticasone Propionate—Desoximetasone—Dexamethasone—multiple sclerosis	0.00125	0.00735	CrCrCtD
Fluticasone Propionate—Desoximetasone—Betamethasone—multiple sclerosis	0.00125	0.00735	CrCrCtD
Fluticasone Propionate—Fluorometholone—Methylprednisolone—multiple sclerosis	0.00124	0.00729	CrCrCtD
Fluticasone Propionate—Triamcinolone—Methylprednisolone—multiple sclerosis	0.00124	0.00729	CrCrCtD
Fluticasone Propionate—Mometasone—Methylprednisolone—multiple sclerosis	0.00124	0.00729	CrCrCtD
Fluticasone Propionate—Fluprednidene Acetate—Methylprednisolone—multiple sclerosis	0.00124	0.00729	CrCrCtD
Fluticasone Propionate—Desoximetasone—Triamcinolone—multiple sclerosis	0.00122	0.00718	CrCrCtD
Fluticasone Propionate—Amcinonide—Prednisolone—multiple sclerosis	0.00122	0.00718	CrCrCtD
Fluticasone Propionate—Mometasone—Betamethasone—multiple sclerosis	0.00122	0.00718	CrCrCtD
Fluticasone Propionate—Triamcinolone—Betamethasone—multiple sclerosis	0.00122	0.00718	CrCrCtD
Fluticasone Propionate—Mometasone—Dexamethasone—multiple sclerosis	0.00122	0.00718	CrCrCtD
Fluticasone Propionate—Fluprednidene Acetate—Dexamethasone—multiple sclerosis	0.00122	0.00718	CrCrCtD
Fluticasone Propionate—Fluprednidene Acetate—Betamethasone—multiple sclerosis	0.00122	0.00718	CrCrCtD
Fluticasone Propionate—Fluorometholone—Dexamethasone—multiple sclerosis	0.00122	0.00718	CrCrCtD
Fluticasone Propionate—Fluorometholone—Betamethasone—multiple sclerosis	0.00122	0.00718	CrCrCtD
Fluticasone Propionate—Triamcinolone—Dexamethasone—multiple sclerosis	0.00122	0.00718	CrCrCtD
Fluticasone Propionate—Flunisolide—Prednisone—multiple sclerosis	0.00121	0.00716	CrCrCtD
Fluticasone Propionate—Clobetasol propionate—Prednisone—multiple sclerosis	0.00121	0.00716	CrCrCtD
Fluticasone Propionate—Diflorasone—Prednisone—multiple sclerosis	0.00121	0.00716	CrCrCtD
Fluticasone Propionate—Dexamethasone—Methylprednisolone—multiple sclerosis	0.00121	0.00712	CrCrCtD
Fluticasone Propionate—Rimexolone—Methylprednisolone—multiple sclerosis	0.00121	0.00712	CrCrCtD
Fluticasone Propionate—Betamethasone—Methylprednisolone—multiple sclerosis	0.00121	0.00712	CrCrCtD
Fluticasone Propionate—Dexamethasone—Betamethasone—multiple sclerosis	0.00119	0.00701	CrCrCtD
Fluticasone Propionate—Rimexolone—Betamethasone—multiple sclerosis	0.00119	0.00701	CrCrCtD
Fluticasone Propionate—Rimexolone—Dexamethasone—multiple sclerosis	0.00119	0.00701	CrCrCtD
Fluticasone Propionate—Betamethasone—Dexamethasone—multiple sclerosis	0.00119	0.00701	CrCrCtD
Fluticasone Propionate—Mometasone—Triamcinolone—multiple sclerosis	0.00119	0.00701	CrCrCtD
Fluticasone Propionate—Fluorometholone—Triamcinolone—multiple sclerosis	0.00119	0.00701	CrCrCtD
Fluticasone Propionate—Fluprednidene Acetate—Triamcinolone—multiple sclerosis	0.00119	0.00701	CrCrCtD
Fluticasone Propionate—Flunisolide—Prednisolone—multiple sclerosis	0.00119	0.00699	CrCrCtD
Fluticasone Propionate—Diflorasone—Prednisolone—multiple sclerosis	0.00119	0.00699	CrCrCtD
Fluticasone Propionate—Clobetasol propionate—Prednisolone—multiple sclerosis	0.00119	0.00699	CrCrCtD
Fluticasone Propionate—Paramethasone—Prednisone—multiple sclerosis	0.00118	0.00698	CrCrCtD
Fluticasone Propionate—Rimexolone—Triamcinolone—multiple sclerosis	0.00116	0.00685	CrCrCtD
Fluticasone Propionate—Betamethasone—Triamcinolone—multiple sclerosis	0.00116	0.00685	CrCrCtD
Fluticasone Propionate—Dexamethasone—Triamcinolone—multiple sclerosis	0.00116	0.00685	CrCrCtD
Fluticasone Propionate—Paramethasone—Prednisolone—multiple sclerosis	0.00116	0.00682	CrCrCtD
Fluticasone Propionate—Desoximetasone—Prednisone—multiple sclerosis	0.00116	0.00681	CrCrCtD
Fluticasone Propionate—Methylprednisolone—Betamethasone—multiple sclerosis	0.00114	0.00671	CrCrCtD
Fluticasone Propionate—Methylprednisolone—Dexamethasone—multiple sclerosis	0.00114	0.00671	CrCrCtD
Fluticasone Propionate—Fluorometholone—Prednisone—multiple sclerosis	0.00113	0.00665	CrCrCtD
Fluticasone Propionate—Mometasone—Prednisone—multiple sclerosis	0.00113	0.00665	CrCrCtD
Fluticasone Propionate—Triamcinolone—Prednisone—multiple sclerosis	0.00113	0.00665	CrCrCtD
Fluticasone Propionate—Fluprednidene Acetate—Prednisone—multiple sclerosis	0.00113	0.00665	CrCrCtD
Fluticasone Propionate—Desoximetasone—Prednisolone—multiple sclerosis	0.00113	0.00665	CrCrCtD
Fluticasone Propionate—Methylprednisolone—Triamcinolone—multiple sclerosis	0.00111	0.00655	CrCrCtD
Fluticasone Propionate—Betamethasone—Prednisone—multiple sclerosis	0.0011	0.0065	CrCrCtD
Fluticasone Propionate—Dexamethasone—Prednisone—multiple sclerosis	0.0011	0.0065	CrCrCtD
Fluticasone Propionate—Rimexolone—Prednisone—multiple sclerosis	0.0011	0.0065	CrCrCtD
Fluticasone Propionate—Mometasone—Prednisolone—multiple sclerosis	0.0011	0.00649	CrCrCtD
Fluticasone Propionate—Fluprednidene Acetate—Prednisolone—multiple sclerosis	0.0011	0.00649	CrCrCtD
Fluticasone Propionate—Fluorometholone—Prednisolone—multiple sclerosis	0.0011	0.00649	CrCrCtD
Fluticasone Propionate—Triamcinolone—Prednisolone—multiple sclerosis	0.0011	0.00649	CrCrCtD
Fluticasone Propionate—Rimexolone—Prednisolone—multiple sclerosis	0.00108	0.00635	CrCrCtD
Fluticasone Propionate—Betamethasone—Prednisolone—multiple sclerosis	0.00108	0.00635	CrCrCtD
Fluticasone Propionate—Dexamethasone—Prednisolone—multiple sclerosis	0.00108	0.00635	CrCrCtD
Fluticasone Propionate—Methylprednisolone—Prednisone—multiple sclerosis	0.00105	0.00622	CrCrCtD
Fluticasone Propionate—Methylprednisolone—Prednisolone—multiple sclerosis	0.00103	0.00607	CrCrCtD
Fluticasone Propionate—CYP3A4—Triamcinolone—multiple sclerosis	0.000988	0.00683	CbGbCtD
Fluticasone Propionate—CYP3A4—Mitoxantrone—multiple sclerosis	0.000951	0.00657	CbGbCtD
Fluticasone Propionate—CYP3A4—Betamethasone—multiple sclerosis	0.000848	0.00586	CbGbCtD
Fluticasone Propionate—CYP3A4—Prednisolone—multiple sclerosis	0.000836	0.00578	CbGbCtD
Fluticasone Propionate—CYP3A4—Prednisone—multiple sclerosis	0.00079	0.00546	CbGbCtD
Fluticasone Propionate—CYP3A4—Dexamethasone—multiple sclerosis	0.000493	0.00341	CbGbCtD
Fluticasone Propionate—PLA2G4A—Raltitrexed—Methotrexate—multiple sclerosis	0.000321	0.546	CbGdCrCtD
Fluticasone Propionate—NR3C1—nerve—multiple sclerosis	0.000103	0.0678	CbGeAlD
Fluticasone Propionate—NR3C2—brainstem—multiple sclerosis	8.24e-05	0.0542	CbGeAlD
Fluticasone Propionate—NR3C2—retina—multiple sclerosis	7.95e-05	0.0523	CbGeAlD
Fluticasone Propionate—PLA2G4A—medulla oblongata—multiple sclerosis	7.06e-05	0.0465	CbGeAlD
Fluticasone Propionate—PLA2G4A—midbrain—multiple sclerosis	6.46e-05	0.0425	CbGeAlD
Fluticasone Propionate—PLA2G4A—spinal cord—multiple sclerosis	6.3e-05	0.0415	CbGeAlD
Fluticasone Propionate—NR3C2—medulla oblongata—multiple sclerosis	5.74e-05	0.0378	CbGeAlD
Fluticasone Propionate—PLA2G4A—nervous system—multiple sclerosis	5.31e-05	0.035	CbGeAlD
Fluticasone Propionate—SERPINA6—nervous system—multiple sclerosis	5.29e-05	0.0348	CbGeAlD
Fluticasone Propionate—NR3C2—midbrain—multiple sclerosis	5.25e-05	0.0346	CbGeAlD
Fluticasone Propionate—NR3C2—spinal cord—multiple sclerosis	5.12e-05	0.0337	CbGeAlD
Fluticasone Propionate—PLA2G4A—central nervous system—multiple sclerosis	5.11e-05	0.0337	CbGeAlD
Fluticasone Propionate—SERPINA6—central nervous system—multiple sclerosis	5.09e-05	0.0335	CbGeAlD
Fluticasone Propionate—SERPINA6—cerebellum—multiple sclerosis	4.97e-05	0.0328	CbGeAlD
Fluticasone Propionate—Betamethasone—PGR—multiple sclerosis	4.65e-05	0.414	CrCbGaD
Fluticasone Propionate—NR3C1—brainstem—multiple sclerosis	4.42e-05	0.0291	CbGeAlD
Fluticasone Propionate—NR3C2—nervous system—multiple sclerosis	4.32e-05	0.0284	CbGeAlD
Fluticasone Propionate—NR3C2—central nervous system—multiple sclerosis	4.16e-05	0.0274	CbGeAlD
Fluticasone Propionate—NR3C2—cerebellum—multiple sclerosis	4.06e-05	0.0267	CbGeAlD
Fluticasone Propionate—PLA2G4A—brain—multiple sclerosis	4.06e-05	0.0267	CbGeAlD
Fluticasone Propionate—SERPINA6—brain—multiple sclerosis	4.04e-05	0.0266	CbGeAlD
Fluticasone Propionate—PGR—nervous system—multiple sclerosis	4.01e-05	0.0264	CbGeAlD
Fluticasone Propionate—Triamcinolone—BCHE—multiple sclerosis	3.89e-05	0.346	CrCbGaD
Fluticasone Propionate—PGR—central nervous system—multiple sclerosis	3.86e-05	0.0254	CbGeAlD
Fluticasone Propionate—PGR—cerebellum—multiple sclerosis	3.78e-05	0.0249	CbGeAlD
Fluticasone Propionate—NR3C2—brain—multiple sclerosis	3.3e-05	0.0217	CbGeAlD
Fluticasone Propionate—NR3C1—medulla oblongata—multiple sclerosis	3.08e-05	0.0203	CbGeAlD
Fluticasone Propionate—PGR—brain—multiple sclerosis	3.07e-05	0.0202	CbGeAlD
Fluticasone Propionate—NR3C1—midbrain—multiple sclerosis	2.82e-05	0.0185	CbGeAlD
Fluticasone Propionate—PLA2G4A—Betamethasone—Methylprednisolone—multiple sclerosis	2.8e-05	0.0477	CbGdCrCtD
Fluticasone Propionate—PLA2G4A—Dexamethasone—Methylprednisolone—multiple sclerosis	2.8e-05	0.0477	CbGdCrCtD
Fluticasone Propionate—PLA2G4A—Dexamethasone—Betamethasone—multiple sclerosis	2.76e-05	0.047	CbGdCrCtD
Fluticasone Propionate—PLA2G4A—Betamethasone—Dexamethasone—multiple sclerosis	2.76e-05	0.047	CbGdCrCtD
Fluticasone Propionate—NR3C1—spinal cord—multiple sclerosis	2.75e-05	0.0181	CbGeAlD
Fluticasone Propionate—Dexamethasone—PGR—multiple sclerosis	2.7e-05	0.241	CrCbGaD
Fluticasone Propionate—PLA2G4A—Dexamethasone—Triamcinolone—multiple sclerosis	2.69e-05	0.0459	CbGdCrCtD
Fluticasone Propionate—PLA2G4A—Betamethasone—Triamcinolone—multiple sclerosis	2.69e-05	0.0459	CbGdCrCtD
Fluticasone Propionate—PLA2G4A—Dexamethasone—Prednisone—multiple sclerosis	2.56e-05	0.0436	CbGdCrCtD
Fluticasone Propionate—PLA2G4A—Betamethasone—Prednisone—multiple sclerosis	2.56e-05	0.0436	CbGdCrCtD
Fluticasone Propionate—PLA2G4A—Betamethasone—Prednisolone—multiple sclerosis	2.5e-05	0.0425	CbGdCrCtD
Fluticasone Propionate—PLA2G4A—Dexamethasone—Prednisolone—multiple sclerosis	2.5e-05	0.0425	CbGdCrCtD
Fluticasone Propionate—Skin disorder—Mitoxantrone—multiple sclerosis	2.48e-05	0.000774	CcSEcCtD
Fluticasone Propionate—Irritability—Methotrexate—multiple sclerosis	2.47e-05	0.000771	CcSEcCtD
Fluticasone Propionate—Vomiting—Cladribine—multiple sclerosis	2.47e-05	0.000771	CcSEcCtD
Fluticasone Propionate—Rash—Cladribine—multiple sclerosis	2.45e-05	0.000764	CcSEcCtD
Fluticasone Propionate—Dermatitis—Cladribine—multiple sclerosis	2.45e-05	0.000764	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Methylprednisolone—multiple sclerosis	2.44e-05	0.000763	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Methylprednisolone—multiple sclerosis	2.44e-05	0.000761	CcSEcCtD
Fluticasone Propionate—Headache—Cladribine—multiple sclerosis	2.43e-05	0.000759	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Triamcinolone—multiple sclerosis	2.42e-05	0.000756	CcSEcCtD
Fluticasone Propionate—Vision blurred—Prednisolone—multiple sclerosis	2.42e-05	0.000755	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Methylprednisolone—multiple sclerosis	2.42e-05	0.000754	CcSEcCtD
Fluticasone Propionate—Hyperglycaemia—Prednisone—multiple sclerosis	2.41e-05	0.000754	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Prednisolone—multiple sclerosis	2.38e-05	0.000743	CcSEcCtD
Fluticasone Propionate—Mental disorder—Methylprednisolone—multiple sclerosis	2.37e-05	0.00074	CcSEcCtD
Fluticasone Propionate—Erythema—Triamcinolone—multiple sclerosis	2.36e-05	0.000737	CcSEcCtD
Fluticasone Propionate—Erythema—Methylprednisolone—multiple sclerosis	2.36e-05	0.000735	CcSEcCtD
Fluticasone Propionate—Malnutrition—Methylprednisolone—multiple sclerosis	2.36e-05	0.000735	CcSEcCtD
Fluticasone Propionate—Angioedema—Prednisolone—multiple sclerosis	2.35e-05	0.000732	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Azathioprine—multiple sclerosis	2.33e-05	0.000726	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	2.33e-05	0.000726	CcSEcCtD
Fluticasone Propionate—NR3C1—nervous system—multiple sclerosis	2.31e-05	0.0152	CbGeAlD
Fluticasone Propionate—Malaise—Prednisolone—multiple sclerosis	2.31e-05	0.000722	CcSEcCtD
Fluticasone Propionate—Nausea—Cladribine—multiple sclerosis	2.31e-05	0.00072	CcSEcCtD
Fluticasone Propionate—Eye disorder—Dexamethasone—multiple sclerosis	2.3e-05	0.000718	CcSEcCtD
Fluticasone Propionate—Eye disorder—Betamethasone—multiple sclerosis	2.3e-05	0.000718	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Mitoxantrone—multiple sclerosis	2.28e-05	0.00071	CcSEcCtD
Fluticasone Propionate—Asthma—Methotrexate—multiple sclerosis	2.24e-05	0.000698	CcSEcCtD
Fluticasone Propionate—NR3C1—central nervous system—multiple sclerosis	2.23e-05	0.0147	CbGeAlD
Fluticasone Propionate—Hypertension—Prednisolone—multiple sclerosis	2.22e-05	0.000692	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Dexamethasone—multiple sclerosis	2.2e-05	0.000686	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Betamethasone—multiple sclerosis	2.2e-05	0.000686	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Triamcinolone—multiple sclerosis	2.19e-05	0.000683	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Methylprednisolone—multiple sclerosis	2.19e-05	0.000682	CcSEcCtD
Fluticasone Propionate—Pain—Mitoxantrone—multiple sclerosis	2.18e-05	0.000681	CcSEcCtD
Fluticasone Propionate—NR3C1—cerebellum—multiple sclerosis	2.18e-05	0.0143	CbGeAlD
Fluticasone Propionate—Diarrhoea—Azathioprine—multiple sclerosis	2.16e-05	0.000674	CcSEcCtD
Fluticasone Propionate—Discomfort—Prednisolone—multiple sclerosis	2.16e-05	0.000674	CcSEcCtD
Fluticasone Propionate—Angioedema—Triamcinolone—multiple sclerosis	2.16e-05	0.000673	CcSEcCtD
Fluticasone Propionate—Angioedema—Methylprednisolone—multiple sclerosis	2.15e-05	0.000672	CcSEcCtD
Fluticasone Propionate—Abdominal discomfort—Methotrexate—multiple sclerosis	2.14e-05	0.000669	CcSEcCtD
Fluticasone Propionate—Erythema—Dexamethasone—multiple sclerosis	2.14e-05	0.000668	CcSEcCtD
Fluticasone Propionate—Erythema—Betamethasone—multiple sclerosis	2.14e-05	0.000668	CcSEcCtD
Fluticasone Propionate—Malaise—Triamcinolone—multiple sclerosis	2.13e-05	0.000664	CcSEcCtD
Fluticasone Propionate—Malaise—Methylprednisolone—multiple sclerosis	2.12e-05	0.000663	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Prednisone—multiple sclerosis	2.11e-05	0.000657	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Mitoxantrone—multiple sclerosis	2.1e-05	0.000657	CcSEcCtD
Fluticasone Propionate—Oedema—Prednisolone—multiple sclerosis	2.09e-05	0.000654	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Prednisolone—multiple sclerosis	2.09e-05	0.000654	CcSEcCtD
Fluticasone Propionate—Dizziness—Azathioprine—multiple sclerosis	2.09e-05	0.000652	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	2.09e-05	0.000652	CcSEcCtD
Fluticasone Propionate—PLA2G4A—PDGF Pathway—STAT3—multiple sclerosis	2.08e-05	0.00388	CbGpPWpGaD
Fluticasone Propionate—Upper respiratory tract infection—Methotrexate—multiple sclerosis	2.08e-05	0.000649	CcSEcCtD
Fluticasone Propionate—Cough—Triamcinolone—multiple sclerosis	2.06e-05	0.000643	CcSEcCtD
Fluticasone Propionate—Tachycardia—Prednisolone—multiple sclerosis	2.04e-05	0.000638	CcSEcCtD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—IL4—multiple sclerosis	2.04e-05	0.00381	CbGpPWpGaD
Fluticasone Propionate—Hypertension—Triamcinolone—multiple sclerosis	2.04e-05	0.000636	CcSEcCtD
Fluticasone Propionate—Hypertension—Methylprednisolone—multiple sclerosis	2.03e-05	0.000635	CcSEcCtD
Fluticasone Propionate—Urticaria—Mitoxantrone—multiple sclerosis	2.03e-05	0.000633	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Mitoxantrone—multiple sclerosis	2.02e-05	0.00063	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Mitoxantrone—multiple sclerosis	2.02e-05	0.00063	CcSEcCtD
Fluticasone Propionate—NR3C1—Transcription factor regulation in adipogenesis—TNF—multiple sclerosis	2.02e-05	0.00376	CbGpPWpGaD
Fluticasone Propionate—Vomiting—Azathioprine—multiple sclerosis	2.01e-05	0.000627	CcSEcCtD
Fluticasone Propionate—Pneumonia—Methotrexate—multiple sclerosis	2.01e-05	0.000626	CcSEcCtD
Fluticasone Propionate—Arthralgia—Methylprednisolone—multiple sclerosis	2.01e-05	0.000626	CcSEcCtD
Fluticasone Propionate—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	2e-05	0.00373	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	2e-05	0.00373	CbGpPWpGaD
Fluticasone Propionate—Eye disorder—Prednisone—multiple sclerosis	2e-05	0.000625	CcSEcCtD
Fluticasone Propionate—Anxiety—Methylprednisolone—multiple sclerosis	2e-05	0.000624	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Methotrexate—multiple sclerosis	1.99e-05	0.000623	CcSEcCtD
Fluticasone Propionate—Infestation—Methotrexate—multiple sclerosis	1.99e-05	0.000623	CcSEcCtD
Fluticasone Propionate—PGR—Signaling by ERBB4—CD86—multiple sclerosis	1.99e-05	0.00371	CbGpPWpGaD
Fluticasone Propionate—Rash—Azathioprine—multiple sclerosis	1.99e-05	0.000622	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	1.99e-05	0.000621	CcSEcCtD
Fluticasone Propionate—Dermatitis—Azathioprine—multiple sclerosis	1.99e-05	0.000621	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Dexamethasone—multiple sclerosis	1.99e-05	0.00062	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Betamethasone—multiple sclerosis	1.99e-05	0.00062	CcSEcCtD
Fluticasone Propionate—Discomfort—Triamcinolone—multiple sclerosis	1.99e-05	0.00062	CcSEcCtD
Fluticasone Propionate—Discomfort—Methylprednisolone—multiple sclerosis	1.98e-05	0.000618	CcSEcCtD
Fluticasone Propionate—Headache—Azathioprine—multiple sclerosis	1.98e-05	0.000618	CcSEcCtD
Fluticasone Propionate—Dry mouth—Triamcinolone—multiple sclerosis	1.97e-05	0.000613	CcSEcCtD
Fluticasone Propionate—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—multiple sclerosis	1.96e-05	0.00366	CbGpPWpGaD
Fluticasone Propionate—Angioedema—Dexamethasone—multiple sclerosis	1.96e-05	0.000611	CcSEcCtD
Fluticasone Propionate—Angioedema—Betamethasone—multiple sclerosis	1.96e-05	0.000611	CcSEcCtD
Fluticasone Propionate—NR3C2—Generic Transcription Pathway—PGR—multiple sclerosis	1.95e-05	0.00364	CbGpPWpGaD
Fluticasone Propionate—Conjunctivitis—Methotrexate—multiple sclerosis	1.94e-05	0.000605	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Prednisone—multiple sclerosis	1.94e-05	0.000604	CcSEcCtD
Fluticasone Propionate—Malaise—Dexamethasone—multiple sclerosis	1.93e-05	0.000603	CcSEcCtD
Fluticasone Propionate—Malaise—Betamethasone—multiple sclerosis	1.93e-05	0.000603	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Triamcinolone—multiple sclerosis	1.93e-05	0.000601	CcSEcCtD
Fluticasone Propionate—Oedema—Triamcinolone—multiple sclerosis	1.93e-05	0.000601	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Methylprednisolone—multiple sclerosis	1.92e-05	0.0006	CcSEcCtD
Fluticasone Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—multiple sclerosis	1.92e-05	0.00358	CbGpPWpGaD
Fluticasone Propionate—Arrhythmia—Prednisone—multiple sclerosis	1.91e-05	0.000597	CcSEcCtD
Fluticasone Propionate—Infection—Triamcinolone—multiple sclerosis	1.91e-05	0.000597	CcSEcCtD
Fluticasone Propionate—Infection—Methylprednisolone—multiple sclerosis	1.91e-05	0.000596	CcSEcCtD
Fluticasone Propionate—PGR—Gene Expression—ZNF746—multiple sclerosis	1.9e-05	0.00354	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—PDGF Pathway—MAPK1—multiple sclerosis	1.89e-05	0.00353	CbGpPWpGaD
Fluticasone Propionate—Nervous system disorder—Methylprednisolone—multiple sclerosis	1.89e-05	0.000588	CcSEcCtD
Fluticasone Propionate—Epistaxis—Methotrexate—multiple sclerosis	1.88e-05	0.000587	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Mitoxantrone—multiple sclerosis	1.88e-05	0.000587	CcSEcCtD
Fluticasone Propionate—Tachycardia—Triamcinolone—multiple sclerosis	1.88e-05	0.000587	CcSEcCtD
Fluticasone Propionate—Mental disorder—Prednisone—multiple sclerosis	1.88e-05	0.000586	CcSEcCtD
Fluticasone Propionate—Nausea—Azathioprine—multiple sclerosis	1.88e-05	0.000586	CcSEcCtD
Fluticasone Propionate—Tachycardia—Methylprednisolone—multiple sclerosis	1.88e-05	0.000585	CcSEcCtD
Fluticasone Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—multiple sclerosis	1.87e-05	0.00348	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Opioid Signalling—POMC—multiple sclerosis	1.87e-05	0.00348	CbGpPWpGaD
Fluticasone Propionate—Skin disorder—Methylprednisolone—multiple sclerosis	1.87e-05	0.000583	CcSEcCtD
Fluticasone Propionate—Erythema—Prednisone—multiple sclerosis	1.87e-05	0.000582	CcSEcCtD
Fluticasone Propionate—Malnutrition—Prednisone—multiple sclerosis	1.87e-05	0.000582	CcSEcCtD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—HLA-A—multiple sclerosis	1.85e-05	0.00345	CbGpPWpGaD
Fluticasone Propionate—Hypertension—Betamethasone—multiple sclerosis	1.85e-05	0.000577	CcSEcCtD
Fluticasone Propionate—Hypertension—Dexamethasone—multiple sclerosis	1.85e-05	0.000577	CcSEcCtD
Fluticasone Propionate—Anxiety—Betamethasone—multiple sclerosis	1.82e-05	0.000567	CcSEcCtD
Fluticasone Propionate—Anxiety—Dexamethasone—multiple sclerosis	1.82e-05	0.000567	CcSEcCtD
Fluticasone Propionate—Discomfort—Dexamethasone—multiple sclerosis	1.8e-05	0.000562	CcSEcCtD
Fluticasone Propionate—Discomfort—Betamethasone—multiple sclerosis	1.8e-05	0.000562	CcSEcCtD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—IL4—multiple sclerosis	1.8e-05	0.00335	CbGpPWpGaD
Fluticasone Propionate—Pain—Prednisolone—multiple sclerosis	1.79e-05	0.000559	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Methotrexate—multiple sclerosis	1.78e-05	0.000555	CcSEcCtD
Fluticasone Propionate—NR3C1—brain—multiple sclerosis	1.77e-05	0.0117	CbGeAlD
Fluticasone Propionate—Vision blurred—Prednisone—multiple sclerosis	1.76e-05	0.000549	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	1.76e-05	0.000548	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	1.75e-05	0.000547	CcSEcCtD
Fluticasone Propionate—CYP3A4—nervous system—multiple sclerosis	1.75e-05	0.0115	CbGeAlD
Fluticasone Propionate—Anaphylactic shock—Betamethasone—multiple sclerosis	1.75e-05	0.000546	CcSEcCtD
Fluticasone Propionate—Oedema—Dexamethasone—multiple sclerosis	1.75e-05	0.000546	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Dexamethasone—multiple sclerosis	1.75e-05	0.000546	CcSEcCtD
Fluticasone Propionate—Oedema—Betamethasone—multiple sclerosis	1.75e-05	0.000546	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Mitoxantrone—multiple sclerosis	1.75e-05	0.000545	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	1.75e-05	0.00325	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	1.75e-05	0.00325	CbGpPWpGaD
Fluticasone Propionate—Infection—Betamethasone—multiple sclerosis	1.74e-05	0.000542	CcSEcCtD
Fluticasone Propionate—Infection—Dexamethasone—multiple sclerosis	1.74e-05	0.000542	CcSEcCtD
Fluticasone Propionate—PGR—Gene Expression—PTBP1—multiple sclerosis	1.74e-05	0.00323	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	1.74e-05	0.00323	CbGpPWpGaD
Fluticasone Propionate—Ill-defined disorder—Prednisone—multiple sclerosis	1.73e-05	0.00054	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Prednisolone—multiple sclerosis	1.73e-05	0.000539	CcSEcCtD
Fluticasone Propionate—PLA2G4A—PLC beta mediated events—MAPK1—multiple sclerosis	1.72e-05	0.0032	CbGpPWpGaD
Fluticasone Propionate—Dyspnoea—Triamcinolone—multiple sclerosis	1.72e-05	0.000536	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Betamethasone—multiple sclerosis	1.71e-05	0.000535	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Dexamethasone—multiple sclerosis	1.71e-05	0.000535	CcSEcCtD
Fluticasone Propionate—Agitation—Prednisone—multiple sclerosis	1.71e-05	0.000535	CcSEcCtD
Fluticasone Propionate—NR3C2—Gene Expression—ZFP36L1—multiple sclerosis	1.71e-05	0.00318	CbGpPWpGaD
Fluticasone Propionate—Tachycardia—Dexamethasone—multiple sclerosis	1.71e-05	0.000532	CcSEcCtD
Fluticasone Propionate—Tachycardia—Betamethasone—multiple sclerosis	1.71e-05	0.000532	CcSEcCtD
Fluticasone Propionate—Angioedema—Prednisone—multiple sclerosis	1.7e-05	0.000532	CcSEcCtD
Fluticasone Propionate—PLA2G4A—G-protein mediated events—MAPK1—multiple sclerosis	1.69e-05	0.00315	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—central nervous system—multiple sclerosis	1.69e-05	0.0111	CbGeAlD
Fluticasone Propionate—Malaise—Prednisone—multiple sclerosis	1.68e-05	0.000525	CcSEcCtD
Fluticasone Propionate—Eye disorder—Methotrexate—multiple sclerosis	1.67e-05	0.000522	CcSEcCtD
Fluticasone Propionate—Urticaria—Prednisolone—multiple sclerosis	1.66e-05	0.000519	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Methotrexate—multiple sclerosis	1.66e-05	0.000519	CcSEcCtD
Fluticasone Propionate—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	1.65e-05	0.00308	CbGpPWpGaD
Fluticasone Propionate—Pain—Triamcinolone—multiple sclerosis	1.65e-05	0.000514	CcSEcCtD
Fluticasone Propionate—NR3C1—Transcription factor regulation in adipogenesis—IL6—multiple sclerosis	1.63e-05	0.00303	CbGpPWpGaD
Fluticasone Propionate—Vomiting—Mitoxantrone—multiple sclerosis	1.62e-05	0.000507	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Methotrexate—multiple sclerosis	1.62e-05	0.000505	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Methotrexate—multiple sclerosis	1.61e-05	0.000504	CcSEcCtD
Fluticasone Propionate—Hypertension—Prednisone—multiple sclerosis	1.61e-05	0.000503	CcSEcCtD
Fluticasone Propionate—Rash—Mitoxantrone—multiple sclerosis	1.61e-05	0.000502	CcSEcCtD
Fluticasone Propionate—Dermatitis—Mitoxantrone—multiple sclerosis	1.61e-05	0.000502	CcSEcCtD
Fluticasone Propionate—Headache—Mitoxantrone—multiple sclerosis	1.6e-05	0.000499	CcSEcCtD
Fluticasone Propionate—PGR—Validated nuclear estrogen receptor alpha network—MYC—multiple sclerosis	1.6e-05	0.00297	CbGpPWpGaD
Fluticasone Propionate—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	1.59e-05	0.000497	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	1.59e-05	0.000497	CcSEcCtD
Fluticasone Propionate—Arthralgia—Prednisone—multiple sclerosis	1.59e-05	0.000496	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Triamcinolone—multiple sclerosis	1.59e-05	0.000495	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Methylprednisolone—multiple sclerosis	1.58e-05	0.000494	CcSEcCtD
Fluticasone Propionate—Anxiety—Prednisone—multiple sclerosis	1.58e-05	0.000494	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	1.58e-05	0.000492	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	1.57e-05	0.000491	CcSEcCtD
Fluticasone Propionate—Discomfort—Prednisone—multiple sclerosis	1.57e-05	0.00049	CcSEcCtD
Fluticasone Propionate—Mental disorder—Methotrexate—multiple sclerosis	1.57e-05	0.00049	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Hemostasis—PLEK—multiple sclerosis	1.56e-05	0.00291	CbGpPWpGaD
Fluticasone Propionate—Erythema—Methotrexate—multiple sclerosis	1.56e-05	0.000486	CcSEcCtD
Fluticasone Propionate—Malnutrition—Methotrexate—multiple sclerosis	1.56e-05	0.000486	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Prednisolone—multiple sclerosis	1.54e-05	0.000482	CcSEcCtD
Fluticasone Propionate—PLA2G4A—AGE/RAGE pathway—MMP9—multiple sclerosis	1.54e-05	0.00287	CbGpPWpGaD
Fluticasone Propionate—Urticaria—Triamcinolone—multiple sclerosis	1.53e-05	0.000478	CcSEcCtD
Fluticasone Propionate—Urticaria—Methylprednisolone—multiple sclerosis	1.53e-05	0.000477	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Triamcinolone—multiple sclerosis	1.52e-05	0.000475	CcSEcCtD
Fluticasone Propionate—Oedema—Prednisone—multiple sclerosis	1.52e-05	0.000475	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Prednisone—multiple sclerosis	1.52e-05	0.000475	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Methylprednisolone—multiple sclerosis	1.52e-05	0.000474	CcSEcCtD
Fluticasone Propionate—Nausea—Mitoxantrone—multiple sclerosis	1.52e-05	0.000473	CcSEcCtD
Fluticasone Propionate—Infection—Prednisone—multiple sclerosis	1.51e-05	0.000472	CcSEcCtD
Fluticasone Propionate—Pain—Dexamethasone—multiple sclerosis	1.49e-05	0.000466	CcSEcCtD
Fluticasone Propionate—Pain—Betamethasone—multiple sclerosis	1.49e-05	0.000466	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Prednisone—multiple sclerosis	1.49e-05	0.000466	CcSEcCtD
Fluticasone Propionate—Tachycardia—Prednisone—multiple sclerosis	1.49e-05	0.000464	CcSEcCtD
Fluticasone Propionate—Skin disorder—Prednisone—multiple sclerosis	1.48e-05	0.000461	CcSEcCtD
Fluticasone Propionate—Vision blurred—Methotrexate—multiple sclerosis	1.47e-05	0.000458	CcSEcCtD
Fluticasone Propionate—PGR—Signaling by ERBB4—CD80—multiple sclerosis	1.45e-05	0.00271	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—CCL2—multiple sclerosis	1.45e-05	0.00271	CbGpPWpGaD
Fluticasone Propionate—Ill-defined disorder—Methotrexate—multiple sclerosis	1.45e-05	0.000451	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Dexamethasone—multiple sclerosis	1.44e-05	0.00045	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Betamethasone—multiple sclerosis	1.44e-05	0.00045	CcSEcCtD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—multiple sclerosis	1.43e-05	0.00266	CbGpPWpGaD
Fluticasone Propionate—Gastrointestinal pain—Dexamethasone—multiple sclerosis	1.43e-05	0.000446	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Betamethasone—multiple sclerosis	1.43e-05	0.000446	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Triamcinolone—multiple sclerosis	1.42e-05	0.000443	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Methylprednisolone—multiple sclerosis	1.42e-05	0.000442	CcSEcCtD
Fluticasone Propionate—Malaise—Methotrexate—multiple sclerosis	1.41e-05	0.000439	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	1.39e-05	0.00259	CbGpPWpGaD
Fluticasone Propionate—Urticaria—Dexamethasone—multiple sclerosis	1.39e-05	0.000433	CcSEcCtD
Fluticasone Propionate—Urticaria—Betamethasone—multiple sclerosis	1.39e-05	0.000433	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Prednisone—multiple sclerosis	1.39e-05	0.000433	CcSEcCtD
Fluticasone Propionate—Dizziness—Prednisolone—multiple sclerosis	1.39e-05	0.000432	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Betamethasone—multiple sclerosis	1.38e-05	0.000431	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Dexamethasone—multiple sclerosis	1.38e-05	0.000431	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Betamethasone—multiple sclerosis	1.38e-05	0.000431	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Dexamethasone—multiple sclerosis	1.38e-05	0.000431	CcSEcCtD
Fluticasone Propionate—PLA2G4A—AGE/RAGE pathway—STAT3—multiple sclerosis	1.37e-05	0.00255	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Generic Transcription Pathway—VDR—multiple sclerosis	1.37e-05	0.00254	CbGpPWpGaD
Fluticasone Propionate—Pruritus—Triamcinolone—multiple sclerosis	1.36e-05	0.000425	CcSEcCtD
Fluticasone Propionate—Cough—Methotrexate—multiple sclerosis	1.36e-05	0.000425	CcSEcCtD
Fluticasone Propionate—Pruritus—Methylprednisolone—multiple sclerosis	1.36e-05	0.000424	CcSEcCtD
Fluticasone Propionate—CYP3A7—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.34e-05	0.0025	CbGpPWpGaD
Fluticasone Propionate—Arthralgia—Methotrexate—multiple sclerosis	1.33e-05	0.000414	CcSEcCtD
Fluticasone Propionate—Chest pain—Methotrexate—multiple sclerosis	1.33e-05	0.000414	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—MAPK1—multiple sclerosis	1.32e-05	0.00247	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—PABPC1—multiple sclerosis	1.32e-05	0.00247	CbGpPWpGaD
Fluticasone Propionate—Rash—Prednisolone—multiple sclerosis	1.32e-05	0.000412	CcSEcCtD
Fluticasone Propionate—Dermatitis—Prednisolone—multiple sclerosis	1.32e-05	0.000412	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	1.32e-05	0.000411	CcSEcCtD
Fluticasone Propionate—PGR—Gene Expression—HNRNPA1—multiple sclerosis	1.32e-05	0.00245	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—U2AF2—multiple sclerosis	1.32e-05	0.00245	CbGpPWpGaD
Fluticasone Propionate—Diarrhoea—Methylprednisolone—multiple sclerosis	1.32e-05	0.00041	CcSEcCtD
Fluticasone Propionate—Headache—Prednisolone—multiple sclerosis	1.31e-05	0.00041	CcSEcCtD
Fluticasone Propionate—Discomfort—Methotrexate—multiple sclerosis	1.31e-05	0.000409	CcSEcCtD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—POMC—multiple sclerosis	1.31e-05	0.00244	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Endothelins—MAPK1—multiple sclerosis	1.29e-05	0.0024	CbGpPWpGaD
Fluticasone Propionate—Dizziness—Triamcinolone—multiple sclerosis	1.27e-05	0.000398	CcSEcCtD
Fluticasone Propionate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	1.27e-05	0.00237	CbGpPWpGaD
Fluticasone Propionate—Anaphylactic shock—Methotrexate—multiple sclerosis	1.27e-05	0.000397	CcSEcCtD
Fluticasone Propionate—Dizziness—Methylprednisolone—multiple sclerosis	1.27e-05	0.000397	CcSEcCtD
Fluticasone Propionate—Infection—Methotrexate—multiple sclerosis	1.26e-05	0.000394	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Prednisone—multiple sclerosis	1.25e-05	0.000391	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Methotrexate—multiple sclerosis	1.25e-05	0.000389	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Prednisone—multiple sclerosis	1.24e-05	0.000388	CcSEcCtD
Fluticasone Propionate—Nausea—Prednisolone—multiple sclerosis	1.24e-05	0.000388	CcSEcCtD
Fluticasone Propionate—PLA2G4A—AGE/RAGE pathway—MAPK1—multiple sclerosis	1.24e-05	0.00232	CbGpPWpGaD
Fluticasone Propionate—Pruritus—Dexamethasone—multiple sclerosis	1.24e-05	0.000386	CcSEcCtD
Fluticasone Propionate—Pruritus—Betamethasone—multiple sclerosis	1.24e-05	0.000386	CcSEcCtD
Fluticasone Propionate—Skin disorder—Methotrexate—multiple sclerosis	1.24e-05	0.000386	CcSEcCtD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—IFNG—multiple sclerosis	1.24e-05	0.0023	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—TYK2—multiple sclerosis	1.23e-05	0.00229	CbGpPWpGaD
Fluticasone Propionate—Vomiting—Triamcinolone—multiple sclerosis	1.22e-05	0.000382	CcSEcCtD
Fluticasone Propionate—Vomiting—Methylprednisolone—multiple sclerosis	1.22e-05	0.000381	CcSEcCtD
Fluticasone Propionate—Rash—Triamcinolone—multiple sclerosis	1.21e-05	0.000379	CcSEcCtD
Fluticasone Propionate—Dermatitis—Triamcinolone—multiple sclerosis	1.21e-05	0.000379	CcSEcCtD
Fluticasone Propionate—Rash—Methylprednisolone—multiple sclerosis	1.21e-05	0.000378	CcSEcCtD
Fluticasone Propionate—Dermatitis—Methylprednisolone—multiple sclerosis	1.21e-05	0.000378	CcSEcCtD
Fluticasone Propionate—Urticaria—Prednisone—multiple sclerosis	1.21e-05	0.000377	CcSEcCtD
Fluticasone Propionate—Headache—Triamcinolone—multiple sclerosis	1.21e-05	0.000377	CcSEcCtD
Fluticasone Propionate—Headache—Methylprednisolone—multiple sclerosis	1.2e-05	0.000376	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Prednisone—multiple sclerosis	1.2e-05	0.000376	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Prednisone—multiple sclerosis	1.2e-05	0.000376	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Dexamethasone—multiple sclerosis	1.2e-05	0.000373	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Betamethasone—multiple sclerosis	1.2e-05	0.000373	CcSEcCtD
Fluticasone Propionate—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	1.2e-05	0.00223	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—RPL5—multiple sclerosis	1.19e-05	0.00223	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	1.19e-05	0.00222	CbGpPWpGaD
Fluticasone Propionate—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	1.16e-05	0.000362	CcSEcCtD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	1.16e-05	0.00216	CbGpPWpGaD
Fluticasone Propionate—Dizziness—Dexamethasone—multiple sclerosis	1.16e-05	0.000361	CcSEcCtD
Fluticasone Propionate—Dizziness—Betamethasone—multiple sclerosis	1.16e-05	0.000361	CcSEcCtD
Fluticasone Propionate—NR3C1—Adipogenesis—FAS—multiple sclerosis	1.15e-05	0.00214	CbGpPWpGaD
Fluticasone Propionate—Nausea—Triamcinolone—multiple sclerosis	1.14e-05	0.000357	CcSEcCtD
Fluticasone Propionate—Nausea—Methylprednisolone—multiple sclerosis	1.14e-05	0.000356	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Methotrexate—multiple sclerosis	1.13e-05	0.000354	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Prednisone—multiple sclerosis	1.12e-05	0.00035	CcSEcCtD
Fluticasone Propionate—Vomiting—Dexamethasone—multiple sclerosis	1.11e-05	0.000347	CcSEcCtD
Fluticasone Propionate—Vomiting—Betamethasone—multiple sclerosis	1.11e-05	0.000347	CcSEcCtD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—IL10—multiple sclerosis	1.11e-05	0.00206	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—SRM—multiple sclerosis	1.1e-05	0.00205	CbGpPWpGaD
Fluticasone Propionate—Rash—Betamethasone—multiple sclerosis	1.1e-05	0.000344	CcSEcCtD
Fluticasone Propionate—Rash—Dexamethasone—multiple sclerosis	1.1e-05	0.000344	CcSEcCtD
Fluticasone Propionate—Dermatitis—Betamethasone—multiple sclerosis	1.1e-05	0.000344	CcSEcCtD
Fluticasone Propionate—Dermatitis—Dexamethasone—multiple sclerosis	1.1e-05	0.000344	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Hemostasis—SELE—multiple sclerosis	1.1e-05	0.00205	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—IL2—multiple sclerosis	1.1e-05	0.00204	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—ZNF746—multiple sclerosis	1.1e-05	0.00204	CbGpPWpGaD
Fluticasone Propionate—Headache—Betamethasone—multiple sclerosis	1.1e-05	0.000342	CcSEcCtD
Fluticasone Propionate—Headache—Dexamethasone—multiple sclerosis	1.1e-05	0.000342	CcSEcCtD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—IFNG—multiple sclerosis	1.09e-05	0.00203	CbGpPWpGaD
Fluticasone Propionate—Pain—Methotrexate—multiple sclerosis	1.09e-05	0.00034	CcSEcCtD
Fluticasone Propionate—Pruritus—Prednisone—multiple sclerosis	1.08e-05	0.000336	CcSEcCtD
Fluticasone Propionate—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	1.06e-05	0.00198	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	1.06e-05	0.00198	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Opioid Signalling—MAPK1—multiple sclerosis	1.06e-05	0.00197	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	1.05e-05	0.00196	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	1.05e-05	0.00196	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	1.05e-05	0.00196	CbGpPWpGaD
Fluticasone Propionate—Feeling abnormal—Methotrexate—multiple sclerosis	1.05e-05	0.000327	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Prednisone—multiple sclerosis	1.04e-05	0.000325	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Methotrexate—multiple sclerosis	1.04e-05	0.000325	CcSEcCtD
Fluticasone Propionate—PGR—Gene Expression—ZFP36L1—multiple sclerosis	1.04e-05	0.00194	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—MMP9—multiple sclerosis	1.04e-05	0.00193	CbGpPWpGaD
Fluticasone Propionate—Nausea—Dexamethasone—multiple sclerosis	1.04e-05	0.000324	CcSEcCtD
Fluticasone Propionate—Nausea—Betamethasone—multiple sclerosis	1.04e-05	0.000324	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—S1PR1—multiple sclerosis	1.03e-05	0.00193	CbGpPWpGaD
Fluticasone Propionate—Urticaria—Methotrexate—multiple sclerosis	1.01e-05	0.000315	CcSEcCtD
Fluticasone Propionate—Dizziness—Prednisone—multiple sclerosis	1.01e-05	0.000314	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Methotrexate—multiple sclerosis	1.01e-05	0.000314	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Methotrexate—multiple sclerosis	1.01e-05	0.000314	CcSEcCtD
Fluticasone Propionate—NR3C1—Gene Expression—PTBP1—multiple sclerosis	1e-05	0.00187	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—LINGO1—multiple sclerosis	9.87e-06	0.00184	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.69e-06	0.00181	CbGpPWpGaD
Fluticasone Propionate—Vomiting—Prednisone—multiple sclerosis	9.68e-06	0.000302	CcSEcCtD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—IL2—multiple sclerosis	9.67e-06	0.0018	CbGpPWpGaD
Fluticasone Propionate—Rash—Prednisone—multiple sclerosis	9.6e-06	0.0003	CcSEcCtD
Fluticasone Propionate—Dermatitis—Prednisone—multiple sclerosis	9.59e-06	0.000299	CcSEcCtD
Fluticasone Propionate—Headache—Prednisone—multiple sclerosis	9.54e-06	0.000298	CcSEcCtD
Fluticasone Propionate—NR3C2—Gene Expression—PGR—multiple sclerosis	9.41e-06	0.00175	CbGpPWpGaD
Fluticasone Propionate—Hypersensitivity—Methotrexate—multiple sclerosis	9.37e-06	0.000293	CcSEcCtD
Fluticasone Propionate—Nausea—Prednisone—multiple sclerosis	9.04e-06	0.000282	CcSEcCtD
Fluticasone Propionate—Pruritus—Methotrexate—multiple sclerosis	9e-06	0.000281	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—RGS1—multiple sclerosis	8.79e-06	0.00164	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Endoderm Differentiation—TGFB1—multiple sclerosis	8.76e-06	0.00163	CbGpPWpGaD
Fluticasone Propionate—Diarrhoea—Methotrexate—multiple sclerosis	8.71e-06	0.000272	CcSEcCtD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—MYC—multiple sclerosis	8.58e-06	0.0016	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—TGFB1—multiple sclerosis	8.56e-06	0.00159	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TAGAP—multiple sclerosis	8.56e-06	0.00159	CbGpPWpGaD
Fluticasone Propionate—Dizziness—Methotrexate—multiple sclerosis	8.41e-06	0.000263	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—GPR65—multiple sclerosis	8.34e-06	0.00155	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—VDR—multiple sclerosis	8.31e-06	0.00155	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—PDGFR-beta signaling pathway—STAT3—multiple sclerosis	8.21e-06	0.00153	CbGpPWpGaD
Fluticasone Propionate—Vomiting—Methotrexate—multiple sclerosis	8.09e-06	0.000252	CcSEcCtD
Fluticasone Propionate—PGR—Gene Expression—PABPC1—multiple sclerosis	8.07e-06	0.0015	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—LINGO1—multiple sclerosis	8.06e-06	0.0015	CbGpPWpGaD
Fluticasone Propionate—Rash—Methotrexate—multiple sclerosis	8.02e-06	0.00025	CcSEcCtD
Fluticasone Propionate—Dermatitis—Methotrexate—multiple sclerosis	8.01e-06	0.00025	CcSEcCtD
Fluticasone Propionate—Headache—Methotrexate—multiple sclerosis	7.97e-06	0.000249	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Hemostasis—ITGA4—multiple sclerosis	7.96e-06	0.00148	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—IFNB1—multiple sclerosis	7.9e-06	0.00147	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—MAPK1—multiple sclerosis	7.81e-06	0.00146	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CYP27B1—multiple sclerosis	7.77e-06	0.00145	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CYP24A1—multiple sclerosis	7.77e-06	0.00145	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—SRM—multiple sclerosis	7.69e-06	0.00143	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—multiple sclerosis	7.64e-06	0.00142	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—PDGFR-beta signaling pathway—MYC—multiple sclerosis	7.63e-06	0.00142	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—ALB—multiple sclerosis	7.63e-06	0.00142	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—CCR1—multiple sclerosis	7.63e-06	0.00142	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—CXCL13—multiple sclerosis	7.63e-06	0.00142	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—U2AF2—multiple sclerosis	7.61e-06	0.00142	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—HNRNPA1—multiple sclerosis	7.61e-06	0.00142	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	7.6e-06	0.00141	CbGpPWpGaD
Fluticasone Propionate—Nausea—Methotrexate—multiple sclerosis	7.56e-06	0.000236	CcSEcCtD
Fluticasone Propionate—PGR—Signaling Pathways—S1PR1—multiple sclerosis	7.48e-06	0.00139	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—PDGFR-beta signaling pathway—MAPK1—multiple sclerosis	7.46e-06	0.00139	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—multiple sclerosis	7.4e-06	0.00138	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—RPL5—multiple sclerosis	7.28e-06	0.00136	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—GPC5—multiple sclerosis	7.28e-06	0.00136	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Biological oxidations—POMC—multiple sclerosis	7.12e-06	0.00133	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—GPC5—multiple sclerosis	7.11e-06	0.00132	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TAGAP—multiple sclerosis	6.99e-06	0.0013	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—PGR—multiple sclerosis	6.88e-06	0.00128	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—VDR—multiple sclerosis	6.57e-06	0.00122	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—IL6—multiple sclerosis	6.45e-06	0.0012	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—RGS1—multiple sclerosis	6.36e-06	0.00118	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	6.18e-06	0.00115	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—S1PR1—multiple sclerosis	6.11e-06	0.00114	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—GPR65—multiple sclerosis	6.03e-06	0.00112	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—ZFP36L1—multiple sclerosis	6.01e-06	0.00112	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—IL6—multiple sclerosis	6e-06	0.00112	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—GPC5—multiple sclerosis	5.94e-06	0.00111	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—RRM1—multiple sclerosis	5.89e-06	0.0011	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	5.8e-06	0.00108	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—IL6—multiple sclerosis	5.69e-06	0.00106	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—STAT3—multiple sclerosis	5.63e-06	0.00105	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.56e-06	0.00104	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—SRM—multiple sclerosis	5.56e-06	0.00103	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CCR1—multiple sclerosis	5.51e-06	0.00103	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CXCL13—multiple sclerosis	5.51e-06	0.00103	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—IL2RA—multiple sclerosis	5.44e-06	0.00101	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	5.43e-06	0.00101	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—CCL3—multiple sclerosis	5.43e-06	0.00101	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Generic Transcription Pathway—MYC—multiple sclerosis	5.43e-06	0.00101	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	5.42e-06	0.00101	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CYP24A1—multiple sclerosis	5.42e-06	0.00101	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CYP27B1—multiple sclerosis	5.42e-06	0.00101	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	5.32e-06	0.00099	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—PTGER4—multiple sclerosis	5.23e-06	0.000974	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—TGFB1—multiple sclerosis	5.22e-06	0.000972	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—RGS1—multiple sclerosis	5.2e-06	0.000968	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Biological oxidations—POMC—multiple sclerosis	5.15e-06	0.000959	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	5.06e-06	0.000943	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—CXCR3—multiple sclerosis	5.05e-06	0.000941	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GPC5—multiple sclerosis	4.95e-06	0.000923	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—GPR65—multiple sclerosis	4.93e-06	0.000917	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—CCR2—multiple sclerosis	4.91e-06	0.000915	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—TNF—multiple sclerosis	4.87e-06	0.000908	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	4.82e-06	0.000898	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—VDR—multiple sclerosis	4.81e-06	0.000895	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	4.73e-06	0.000881	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—PABPC1—multiple sclerosis	4.66e-06	0.000868	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.57e-06	0.000851	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—CNR1—multiple sclerosis	4.53e-06	0.000845	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.51e-06	0.000839	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CXCL13—multiple sclerosis	4.5e-06	0.000839	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CCR1—multiple sclerosis	4.5e-06	0.000839	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	4.21e-06	0.000784	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—RPL5—multiple sclerosis	4.21e-06	0.000783	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—RRM1—multiple sclerosis	4.1e-06	0.000764	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—CXCL10—multiple sclerosis	4.08e-06	0.00076	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—VDR—multiple sclerosis	4e-06	0.000746	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—IL6—multiple sclerosis	3.93e-06	0.000732	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—ALB—multiple sclerosis	3.93e-06	0.000732	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CCL3—multiple sclerosis	3.93e-06	0.000732	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.93e-06	0.000731	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	3.92e-06	0.000729	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	3.92e-06	0.000729	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PTGER4—multiple sclerosis	3.78e-06	0.000704	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CXCR3—multiple sclerosis	3.65e-06	0.00068	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CD28—multiple sclerosis	3.62e-06	0.000674	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GPC5—multiple sclerosis	3.58e-06	0.000667	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.58e-06	0.000667	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CCR2—multiple sclerosis	3.55e-06	0.000662	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—CCL5—multiple sclerosis	3.51e-06	0.000655	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	3.4e-06	0.000633	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—BCHE—multiple sclerosis	3.38e-06	0.00063	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—PGR—multiple sclerosis	3.31e-06	0.000617	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—MYC—multiple sclerosis	3.3e-06	0.000615	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CNR1—multiple sclerosis	3.28e-06	0.000611	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CCL3—multiple sclerosis	3.21e-06	0.000598	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—IL2—multiple sclerosis	3.19e-06	0.000594	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—CCR5—multiple sclerosis	3.17e-06	0.00059	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—IL2RA—multiple sclerosis	3.12e-06	0.000581	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PTGER4—multiple sclerosis	3.09e-06	0.000575	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PGR—multiple sclerosis	3.04e-06	0.000567	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CXCR3—multiple sclerosis	2.98e-06	0.000556	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—RRM1—multiple sclerosis	2.97e-06	0.000553	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CD28—multiple sclerosis	2.96e-06	0.000551	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CXCL10—multiple sclerosis	2.95e-06	0.00055	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CCR2—multiple sclerosis	2.9e-06	0.000541	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CNR1—multiple sclerosis	2.68e-06	0.000499	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—MYC—multiple sclerosis	2.61e-06	0.000487	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SRM—multiple sclerosis	2.58e-06	0.000481	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CD86—multiple sclerosis	2.58e-06	0.000481	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CCL5—multiple sclerosis	2.54e-06	0.000473	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—TGFB1—multiple sclerosis	2.49e-06	0.000463	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—POMC—multiple sclerosis	2.47e-06	0.000461	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—MAPK1—multiple sclerosis	2.44e-06	0.000454	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—CCL2—multiple sclerosis	2.42e-06	0.000451	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CXCL10—multiple sclerosis	2.41e-06	0.000449	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.39e-06	0.000446	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—BCHE—multiple sclerosis	2.36e-06	0.000439	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SPP1—multiple sclerosis	2.35e-06	0.000438	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—VDR—multiple sclerosis	2.31e-06	0.000431	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CCR5—multiple sclerosis	2.29e-06	0.000426	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IL2RA—multiple sclerosis	2.26e-06	0.00042	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—TYK2—multiple sclerosis	2.2e-06	0.000409	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CD86—multiple sclerosis	2.11e-06	0.000393	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—APOE—multiple sclerosis	2.08e-06	0.000388	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CCL5—multiple sclerosis	2.08e-06	0.000387	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—APOE—multiple sclerosis	2.04e-06	0.000379	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SPP1—multiple sclerosis	1.92e-06	0.000358	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—MYC—multiple sclerosis	1.91e-06	0.000356	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CD80—multiple sclerosis	1.88e-06	0.000351	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CCR5—multiple sclerosis	1.87e-06	0.000348	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IL2RA—multiple sclerosis	1.84e-06	0.000343	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—IL2—multiple sclerosis	1.83e-06	0.000341	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.82e-06	0.000339	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.82e-06	0.000339	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—POMC—multiple sclerosis	1.79e-06	0.000333	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CCL2—multiple sclerosis	1.75e-06	0.000326	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—POMC—multiple sclerosis	1.75e-06	0.000326	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—BCHE—multiple sclerosis	1.7e-06	0.000317	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—APOE—multiple sclerosis	1.7e-06	0.000317	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.66e-06	0.00031	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—ALB—multiple sclerosis	1.59e-06	0.000297	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—MYC—multiple sclerosis	1.59e-06	0.000296	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TYK2—multiple sclerosis	1.59e-06	0.000296	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CD80—multiple sclerosis	1.54e-06	0.000287	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—POMC—multiple sclerosis	1.46e-06	0.000272	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CCL2—multiple sclerosis	1.43e-06	0.000266	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—APOE—multiple sclerosis	1.42e-06	0.000264	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—MAPK1—multiple sclerosis	1.4e-06	0.000261	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.38e-06	0.000257	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IL2—multiple sclerosis	1.32e-06	0.000246	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TYK2—multiple sclerosis	1.3e-06	0.000242	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MMP9—multiple sclerosis	1.25e-06	0.000233	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—POMC—multiple sclerosis	1.22e-06	0.000227	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—STAT3—multiple sclerosis	1.11e-06	0.000207	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ALB—multiple sclerosis	1.11e-06	0.000207	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IL2—multiple sclerosis	1.08e-06	0.000201	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—IL6—multiple sclerosis	1.08e-06	0.0002	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MYC—multiple sclerosis	1.03e-06	0.000193	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TGFB1—multiple sclerosis	1.03e-06	0.000192	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—APOE—multiple sclerosis	1.03e-06	0.000191	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MMP9—multiple sclerosis	1.02e-06	0.000191	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MAPK1—multiple sclerosis	1.01e-06	0.000188	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—MYC—multiple sclerosis	9.2e-07	0.000171	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—STAT3—multiple sclerosis	9.09e-07	0.000169	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—POMC—multiple sclerosis	8.81e-07	0.000164	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MYC—multiple sclerosis	8.45e-07	0.000157	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TGFB1—multiple sclerosis	8.43e-07	0.000157	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MAPK1—multiple sclerosis	8.27e-07	0.000154	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ALB—multiple sclerosis	8.03e-07	0.00015	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—BCHE—multiple sclerosis	7.92e-07	0.000148	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IL6—multiple sclerosis	7.78e-07	0.000145	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IL6—multiple sclerosis	6.35e-07	0.000118	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—APOE—multiple sclerosis	4.77e-07	8.88e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—POMC—multiple sclerosis	4.09e-07	7.63e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ALB—multiple sclerosis	3.73e-07	6.95e-05	CbGpPWpGaD
